Drug makers stick by China
Life sciences companies establishing roots despite contamination trouble
At the same time medical imports from China are raising safety concerns worldwide, some local life sciences companies are expanding manufacturing operations there. (Full article: 1063 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
